Literature DB >> 16550170

In vivo RNA interference demonstrates a role for Nramp1 in modifying susceptibility to type 1 diabetes.

Stephan Kissler1, Patrick Stern, Kazue Takahashi, Kara Hunter, Laurence B Peterson, Linda S Wicker.   

Abstract

Type 1 diabetes is an autoimmune disease influenced by multiple genetic loci. Although more than 20 insulin-dependent diabetes (Idd) loci have been implicated in the nonobese diabetic (NOD) mouse model, few causal gene variants have been identified. Here we show that RNA interference (RNAi) can be used to probe candidate genes in this disease model. Slc11a1 encodes a phagosomal ion transporter, Nramp1, that affects resistance to intracellular pathogens and influences antigen presentation. This gene is the strongest candidate among the 42 genes in the Idd5.2 region; a naturally occurring mutation in the protective Idd5.2 haplotype results in loss of function of the Nramp1 protein. Using lentiviral transgenesis, we generated NOD mice in which Slc11a1 is silenced by RNAi. Silencing reduced the frequency of type 1 diabetes, mimicking the protective Idd5.2 region. Our results demonstrate a role for Slc11a1 in modifying susceptibility to type 1 diabetes and illustrate that RNAi can be used to study causal genes in a mammalian model organism.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16550170     DOI: 10.1038/ng1766

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  59 in total

1.  The functional SLC11A1 gene polymorphisms are associated with sarcoidosis in Turkish population.

Authors:  Pinar Akçakaya; Benura Azeroglu; Ipek Even; Omer Ates; Hatice Turker; Gul Ongen; Aysegul Topal-Sarikaya
Journal:  Mol Biol Rep       Date:  2011-12-08       Impact factor: 2.316

Review 2.  Use of nonobese diabetic mice to understand human type 1 diabetes.

Authors:  Terri C Thayer; S Brian Wilson; Clayton E Mathews
Journal:  Endocrinol Metab Clin North Am       Date:  2010-07-08       Impact factor: 4.741

Review 3.  Type 1 diabetes therapy beyond T cell targeting: monocytes, B cells, and innate lymphocytes.

Authors:  F Susan Wong; Li Wen
Journal:  Rev Diabet Stud       Date:  2012-12-28

4.  A system for Cre-regulated RNA interference in vivo.

Authors:  Patrick Stern; Sophie Astrof; Stefan J Erkeland; Joshua Schustak; Phillip A Sharp; Richard O Hynes
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-08       Impact factor: 11.205

Review 5.  Engineering humanized mice for improved hematopoietic reconstitution.

Authors:  Adam C Drake; Qingfeng Chen; Jianzhu Chen
Journal:  Cell Mol Immunol       Date:  2012-03-19       Impact factor: 11.530

6.  Genetic interactions among Idd3, Idd5.1, Idd5.2, and Idd5.3 protective loci in the nonobese diabetic mouse model of type 1 diabetes.

Authors:  Xiaotian Lin; Emma E Hamilton-Williams; Daniel B Rainbow; Kara M Hunter; Yang D Dai; Jocelyn Cheung; Laurence B Peterson; Linda S Wicker; Linda A Sherman
Journal:  J Immunol       Date:  2013-02-20       Impact factor: 5.422

7.  Linking chronic infection and autoimmune diseases: Mycobacterium avium subspecies paratuberculosis, SLC11A1 polymorphisms and type-1 diabetes mellitus.

Authors:  Daniela Paccagnini; Lee Sieswerda; Valentina Rosu; Speranza Masala; Adolfo Pacifico; Maria Gazouli; John Ikonomopoulos; Niyaz Ahmed; Stefania Zanetti; Leonardo A Sechi
Journal:  PLoS One       Date:  2009-09-21       Impact factor: 3.240

8.  Idd loci synergize to prolong islet allograft survival induced by costimulation blockade in NOD mice.

Authors:  Julie Mangada; Todd Pearson; Michael A Brehm; Linda S Wicker; Laurence B Peterson; Leonard D Shultz; David V Serreze; Aldo A Rossini; Dale L Greiner
Journal:  Diabetes       Date:  2008-11-04       Impact factor: 9.461

9.  Idd9.1 locus controls the suppressive activity of FoxP3+CD4+CD25+ regulatory T-cells.

Authors:  Jun Yamanouchi; Maria-Carmen Puertas; Joan Verdaguer; Paul A Lyons; Daniel B Rainbow; Giselle Chamberlain; Kara M Hunter; Laurence B Peterson; Linda S Wicker; Pere Santamaria
Journal:  Diabetes       Date:  2009-10-15       Impact factor: 9.461

10.  Specific immunoassays confirm association of Mycobacterium avium Subsp. paratuberculosis with type-1 but not type-2 diabetes mellitus.

Authors:  Valentina Rosu; Niyaz Ahmed; Daniela Paccagnini; Gerald Gerlach; Giovanni Fadda; Seyed E Hasnain; Stefania Zanetti; Leonardo A Sechi
Journal:  PLoS One       Date:  2009-02-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.